Sanjay Srinivasan, Mutalik Deepashri, Gowda Sunil, Mahendradas Padmamalini, Kawali Ankush, Shetty Rohit
Department of Uvea and Ocular Immunology, Naryana Nethralaya, Bangalore, India.
Department of Ear, Nose and Throat, St Martha's Hospital, Bangalore, India.
SN Compr Clin Med. 2021;3(9):1843-1847. doi: 10.1007/s42399-021-00985-2. Epub 2021 Jun 7.
Coronavirus disease (COVID-19) can be associated with ophthalmic manifestations like conjunctivitis, retinal haemorrhages, retinal vascular occlusions, papillophlebitis, and Adie's syndrome. We herein report for a case of a unilateral acute anterior uveitis which was quiescent for 13 years and was reactivated post COVID-19 infection in a 43-year-old Asian Indian male. He had a past history of recurrent unilateral granulomatous anterior and intermediate uveitis in the right eye (RE), and all the investigations done 14 years ago were negative and had been on treatment with topical and oral steroids. He developed cataract 6 months later in the RE and underwent surgery. Patient was in remission for the past 13 years. Uveitis investigations for the present episode were all negative. Topical steroid and cycloplegic helped in resolution of the uveitis. This may be the first instance of reactivation of a quiescent unilateral anterior uveitis following COVID-19 infection.
冠状病毒病（COVID-19）可能伴有眼部表现，如结膜炎、视网膜出血、视网膜血管阻塞、视乳头静脉炎和阿狄氏综合征。我们在此报告一例43岁亚洲印度男性患者，其单侧急性前葡萄膜炎已静止13年，在感染COVID-19后复发。他既往有右眼复发性单侧肉芽肿性前葡萄膜炎和中间葡萄膜炎病史，14年前进行的所有检查均为阴性，一直接受局部和口服类固醇治疗。6个月后他右眼发生白内障并接受了手术。患者在过去13年中病情缓解。此次葡萄膜炎发作的相关检查均为阴性。局部使用类固醇和睫状肌麻痹剂有助于葡萄膜炎的消退。这可能是COVID-19感染后静止性单侧前葡萄膜炎复发的首例病例。
